ArticleEClinicalMedicine2025
Shorter or biomarker-guided antibiotic durations for common serious neonatal infections: a collection of non-inferiority meta-analyses.
Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Is the Neonatal Sepsis Screen More Futile than Useful in Clinical Practice? No.Indian pediatrics · 2026Article
- The Angel in the Marble: Antibiotic Duration in the Neonatal Intensive Care Unit.Antibiotics (Basel, Switzerland) · 2026Review
- Etiopathogenesis and Antibacterial Therapy Approach in Patients with Acute Obstructive Pyelonephritis-A Retrospective Study.Antibiotics (Basel, Switzerland) · 2026Article
- Current Trends and Future Directions in the Diagnosis and Management of Pediatric Orthopedic Disorders.Cureus · 2026Review
- Antibiotic-induced gut microbiota dysbiosis in the PICU: mechanisms, clinical outcomes, and management strategies - a narrative review.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Unnecessary antibiotic prolongation promotes antimicrobial resistance. Evidence-based guidance on antibiotic durations for treating neonatal infections is lacking. Noninferiority meta-analyses evaluating shorter durations or biomarker-guided durations have not been conducted. Methods: We conducted systematic reviews and meta-analyses using a unified search strategy (MEDLINE, EMBASE, Cochrane Library, January 1990-December 2024) to determine whether short-course antibiotics are noninferior to "standard" courses for culture-positive sepsis, culture-negative sepsis, UTIs, uncomplicated/complicated meningitis, and fungal sepsis. Likewise, we determined whether biomarker-guided antibiotic durations are noninferior to "standard" courses for any sepsis. We included randomized controlled trials (RCTs) without language restriction comparing short-courses or biomarker-guided courses versus standard courses for treating the above neonatal infections. Minimum clinically important differences (MCIDs) for critical outcomes were pre-specified [mortality (28-day, in-hospital or 12-month corrected age) = +1%, culture-positive relapse = +3%, culture-negative relapse = +5%]. We evaluated risk of bias (Cochrane RoB 2.0) and certainty of evidence (CoE) using GRADE. Registration: PROSPERO CRD42023311895. Findings: We reviewed 146 full-text articles and included 26 in the review. For culture-positive sepsis (7 randomized controlled trials [RCTs]), 7-10-day courses were noninferior to longer courses for 28-day mortality [upper bound of 95% CI for risk difference +0.85%, below 1% MCID (low CoE)], in-hospital mortality [+0.51% (moderate CoE)], culture-positive relapse [+0.75%, below 3% MCID (low CoE)], culture-negative relapse [+4.7%, below 5% MCID (very low CoE)]. For culture-negative and -positive sepsis, biomarker-guided courses (5 RCTs) were noninferior to standard courses for mortality and relapses (all very low CoE). For culture-negative sepsis (6 RCTs), shorter courses (3-4 days) were noninferior for culture-positive relapses (very low CoE) but Interpretation: Compared to standard durations, 7-10-day antibiotic courses and biomarker-guided courses may be noninferior for treating culture-positive neonatal sepsis and any sepsis, respectively. Three-to-four-day courses may Funding: Not funded.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.